Hradyk Т., & Tsysnetska А. (2022). The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. Actual Problems of Medicine and Pharmacy, 3(1), 1–10. https://doi.org/10.52914/apmp.v3i1.42